Evolus
Price & Volume
Stats
See more52W Range | $3.86-$9.12 |
Market Cap | $592.8M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $316.4M |
Revenue Growth (YoY) | 21.2% |
Gross Profit (12 Mos) | $211.2M |
Diluted EPS | -$0.53 |
News
See moreYahoo Finance • 21 days ago
Evolus targets $450M-$500M revenue and 13%-15% adjusted EBITDA margin in 2028 while raising 2026 revenue outlook to $330M-$337M
Yahoo Finance • 5 months ago
Revance CEO Nadeem Moiz on Expansion, Opportunities & Capitalization
Yahoo Finance • 5 months ago
Telix Appoints David Gill as Non-Executive Director
Yahoo Finance • 5 months ago
Evolus Sees Toxin Market Stabilizing, Evolysse Gaining Traction, Raises 2028 Revenue Targets at Conference
About
CEO | Mr. David Moatazedi |
Address | 520 Newport Center Drive, Newport Beach, CA, United States, 92660 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 353 |